Key Highlights

  • Revenue was A$250.0 million, up 2.5% in constant currency.
  • Cash EBITDA rose 47.1% to A$61.1 million, a Margin of 24.5%.
  • Statutory net profit after tax rose 85.0% to A$32.0 million.
  • Recurring subscription income makes up about 95% of group revenue.

How can a software company report sharply higher Earnings when its Revenue is growing at only a low single-digit pace? Iress (ASX:IRE)'s half-year result, released on 17 August 2026, offers a clear answer: a cost-reduction program is doing most of the work. The result also raises the next question, which is what happens once the savings are banked and growth must come from product rather than efficiency.

What Iress does

Iress provides software and data to the financial services industry. Revenue is mostly recurring subscription income, which the company puts at 95% of group revenue in the latest half. That recurring base gives earnings a degree of stability, but it also means growth depends on pricing, new products and customer retention rather than sales volumes.

Half-year results

Revenue: A$250.0 million, up 2.5% in constant currency.

Cash EBITDA: A$61.1 million, up 47.1%, a margin of 24.5%.

Statutory net profit after tax: A$32.0 million, up 85.0%.

Underlying profit after tax: A$38.8 million, up 18.4%.

Interim dividend: 14.0 cents per share, fully franked, up 27.3%.

Leverage: reduced to 0.5 times.

The profit growth is far higher than revenue growth, and the explanation is cost. Iress's Business efficiency program delivered A$31.5 million in annualised savings, running ahead of expectations, with more expected in the second half. Because those savings flow straight to earnings, they explain how EBITDA could rise by almost half on revenue growth of 2.5%. Savings are finite, so the contribution of this lever fades over time. The 85.0% rise in statutory profit also exceeds the growth in Underlying Profit of 18.4%, which suggests one-off items or lower non-recurring costs helped the statutory figure, although the company update did not itemise them.

Guidance

Iress updated its guidance for FY26, which for a December year-end company covers calendar 2026. Revenue growth is now expected to be 1% to 2%, which is softer than before. Cash EBITDA growth is expected at 21% to 26% and underlying profit after tax growth at 15% to 21%, and the company maintained a target of reaching a cash EBITDA margin run-rate of 25% on exit. These are company expectations, not forecasts from us, and the lower revenue guidance is the number to watch.

Management said second-half Investment in product development would rise, focused on AI capabilities and speeding improvements to Xplan, including through a Partnership with Thoughtworks. This means some of the savings will be reinvested, which could limit further margin expansion.

Portfolio changes

Anyone analysing the long-term trend should read the notes to the accounts, because continuing-operations comparisons can differ significantly from group figures.

Competitive position

Iress competes with other Wealth Management and trading technology providers, including large global vendors and local specialists, and with in-house systems at larger institutions. Its strength is its entrenched position within adviser workflows, which makes switching costly. Its weakness has been the pace of growth, as management's own revenue guidance shows.

Like other software companies, Iress faces questions about whether AI will make its products more useful or easier to replace. That is a risk and an opportunity that remains unproven.

Risks and what to monitor

Revenue growth: guidance of 1% to 2% leaves little room for error, and further softness would weigh on the earnings story.

Cost savings: the contribution of the efficiency program will diminish, and reinvestment could slow margin gains.

Product execution: delivery of AI capabilities and Xplan improvements on time.

Customer concentration and industry change: adviser consolidation, regulation and competitor products.

Currency: reported figures include foreign operations, so exchange rates matter.

Data quality: the gap between cash EBITDA, underlying profit and statutory profit requires care.

Upcoming developments

The second-half result for calendar 2026, due in early 2027, will show whether the company reaches the 25% exit margin and whether revenue growth lands inside the 1% to 2% range. Investors may also look for updates on the product roadmap and any further portfolio decisions.

The takeaway

Iress is delivering on cost and margin improvement, with Leverage low and the dividend higher, but revenue growth is weak. The next phase depends on converting investment in product into top-line growth.